BioSystem Development, a Madison, WI-based company that creates, manufactures and markets tools and products to meet the growing analytical needs of pharmaceutical development, closed a $1m funding.
Backers include angel investors, which committed a total of $750k of new equity, and the Madison Development Corporate Venture Debt Fund, which contributed via a $300k loan.
The company intends to use the funds to scale up its manufacturing capabilities, commercialize new products, and expand its pipeline.
Led by Founder and CEO Scott Fulton, BioSystem has developed AssayMAP Bravo® system, which based on disposable micro‐chromatography cartridges and automation, enables high throughput solutions for bioprocess development, biomarkers and general life science research. It was co-developed with Agilent Technologies.